Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

propisomide

Known as: 2-(2-(diisopropylamino)ethyl)-4-methyl-2-(2-pyridyl)pentamide, PENTISOMIDE, penticainide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
  • I. Khan, R. Gowda
  • International journal of cardiology
  • 2004
  • Corpus ID: 19644596
Long-QT syndrome is a clinically and genetically heterogeneous syndrome characterized by lengthening of the QT interval and… Expand
1992
1992
Voltage-dependent modification of Vmax (the maximum upstroke velocity of the action potential) recovery from use-dependent block… Expand
1992
1992
The interactions of the class I antiarrhythmic agents, disopyramide, pirmenol, and pentisomide with peripheral muscarinic… Expand
1991
1991
1. The effect of the local anaesthetic penticainide (2‐alkyl‐(4‐dialkylamino)‐2‐pyridyl‐butyramide) on macroscopic and single… Expand
1991
1991
Effects of new antiarrhythmic drugs, pentisomide [3.5 ± 0.5 mg/kg intravenously (i.v.) n = 8], and E-4031 (5.6 ± 1.0 μg/kg, n = 8… Expand
1989
1989
1. The blocking mechanism of a disopyramide derivative Penticainide (2‐alkyl‐(4‐(dialkylamino)‐2‐)pyridyl‐butyramide) on cardiac… Expand
1989
1989
The intracellular electrophysiological properties of a new antiarrhythmic agent, penticainide (5 X 10-6 to 5 X 10-5 M) were… Expand
1988
1988
The electrophysiological effects of three class I antiarrhythmic drugs, lignocaine, disopyramide, and penticainide, were compared… Expand
1988
1988
The blocking mechanism of the Na+ channel by penticainide, a disopyramide analogue, was studied in rabbit cardiac Purkinje fibers… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
1987
1987
The antiarrhythmic efficacy of a new class I agent, penticainide, was evaluated by acute oral drug testing and compared in the… Expand